Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Publications: MRSA (Methicillin-resistant Staphylococcus aureus)

2005 to Present (9-site surveillance):

  • Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, Lessa FC, Lynfield R, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Fridkin S; Emerging Infections Program–Active Bacterial Core Surveillance MRSA Surveillance Investigators. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med. 2013;173(21):1970-8.
  • Duffy J, Dumyati G, Bulens S, Namburi S, Gellert A, Fridkin SK, Lessa FC. Community-onset invasive methicillin-resistant Staphylococcus aureus infections following hospital discharge. Am J Infect Control. 2013;41(9):782-6.
  • Iwamoto M, Mu Y, Lynfield R, Bulens, SN, Nadle J, Aragon D, Petit S, Ray SM, Harrison LH, Dumyati G, Townes JM, Schaffner W, Gorwitz RJ, Lessa FC. Trends in Invasive Methicillin-Resistant Staphylococcus aureus infections. Pediatrics. 2013;132(40):e817-24.
  • Nguyen DB, Lessa FC, Belflower R, Mu Y, Wise M, Nadle J, Bamberg WM, Petit S, Ray SM, Harrison LH, Lynfield R, Dumyati G, Thompson J, Schaffner W, Patel PR; for the Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program. Invasive Methicillin-Resistant Staphylococcus aureus Infections aAmong Chronic Dialysis Patients in the United States, 2005-2011. Clin Infect Dis. 2013;57:1393-400.
  • Tosh PK, Bulens SN, Nadle J, Dumyati G, Lynfield R, Schaffner W, Ray S, Seema J, Fridkin SK, Sievert DM.  Characterization of Hospitalized Community-Onset Staphylococcus aureus Lower Respiratory Tract Infections Among Generally Healthy Persons 50 years of Age or Younger. Infect Dis Clin Prac.2013;21:359-65.
  • Bender JB, Waters KC, Nerby J, Olsen KE, Jawahir S. Methicillin-resistant Staphylococcus aureus (MRSA) isolated from pets living in households with MRSA-infected children. Clin Infect Dis. February 2012;54(3):449-50.
  • Hadler JL, Petit S, Mandour M, Cartter ML. Trends in Invasive Infection with Methicillin-Resistant Staphylococcus aureus, Connecticut, 2001-2010. Emerg Infect Dis. 2012 June; 18(6):917-924.
  • Lessa FC, Mu Y, Ray SM, Dumyati G, Bulens S, Gorwitz RJ, Fosheim G, Devries A, Schaffner W, Nadle J, Gershman K, Fridkin SK for the Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program. Impact of USA300 Methicillin-Resistant Staphylococcus aureus on Clinical Outcomes of Patients with Pneumonia or Central Line-Associated Bloodstream Infections. Clin Infect Dis. 2012 Jul; 55(2): 232-41.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2011 [3 pages].
  • DeVries A, Lesher L, Schlievert PM, Rogers T, Gomez-Villaume L, Danila R, et al. Staphylococcal toxic shock syndrome 2000-2006: Epidemiology, clinical features, and molecular characteristics. PLoS One. 2011: 6(8):e22997.
  • Nerby JM, Gorwitz R, Lesher L, Juni B, Jawahir S, Lynfield R, et al. Risk factors for household transmission of community-associated methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J. 2011;30(11):927-932.
  • Satola SW, Lessa FC, Ray SM, Bulens SN, Lynfield R, Schaffner W, et al. Clinical and laboratory characteristics of invasive infections due to methicillin-resistant Staphylococcus aureus isolates demonstrating a vancomycin MIC of 2 micrograms per milliliter: Lack of effect of heteroresistant vancomycin-intermediate S. aureus phenotype. J Clin Microbiol. 2011;49(4):1583-87.
  • Satola SW, Farley MM, Anderson KF, Patel JB. Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method. J Clin Microbiol. 2011;49(1):177-83.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2010 [4 pages].
  • Como-Sabetti KJ, Harriman KH, Fridkin SK, Jawahir SL, Lynfield R. Risk factors for community-associated Staphylococcus aureus infections: Results from parallel studies including methicillin-resistant and methicillin-sensitive S. aureus compared to uninfected controls. Epidemiol Infect. 2010;1:1-11.
  • Kempker RR, Farley MM, Ladson JL, Satola S, Ray SM. Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA Bacteremia. J Infect. 2010;61:372-81.
  • Lessa FC, Mu Y, Davies J, Murray M, Lillie M, Pearson A, et al. Comparison of Incidence of Bloodstream Infection with Methicillin-Resistant Staphylococcus aureus between England and United States, 2006-2007. Clin Infect Dis 2010;51(8):925-28.
  • Shukla SK, Karow ME, Brady JM, Stemper ME, Kislow J, Moore N, et al. Virulence genes and genotypic associations in nasal carriage, community-associated methicillin-susceptible and methicillin-resistant USA400 Staphylococcus aureus isolates. J Clin Microbiol. 2010;48(10):3582-92.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2009 [3 pages].
  • Limbago B, Fosheim GE, Schoonover V, Crane CE, Nadle J, Petit S, et al. Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol 2009;47(5):1344-51.
  • Lucero CA, Hageman J, Zell ER, Bulens S, Nadle J, Petit S, et al. Evaluating the potential public health impact of a Staphylococcus aureus vaccine through the use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States. Vaccine 2009;27(37):5061-68.
  • Buck JM, Harriman KH, Juni BA, Gall K, Boxrud DJ, Glennen A, et al. No change in methicillin-resistant Staphylococcus aureus nasal colonization rates among Minnesota school children during 2 study periods. Infect Dis Clin Pract 2008;16(3):163-5.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2008.
  • Tenover FC, McAllister S, Fosheim G, McDougal LK, Carey RB, Limbago B, et al. Characterization of Staphylococcus aureus Isolates from Nasal Cultures Collected from Individuals in the United States in 2001 to 2004. J Clin Microbiol 2008;46(9):2837-41.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2007.
  • Klevens MR, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States. JAMA 2007; 298(15):1763-71.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2006
  • Klevens MR, Morrison MA, Fridkin SK, Reingold A, Petit S, Gershman K, et al. Community-associate Methicillin-resistant Staphylococcus aureus and Healthcare Risk Factors. Emerg Infec Dis 2006;12:1991-3.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2005.
  • Buck JM, Como-Sabetti K, Harriman KH, Danila RN, Boxrud DJ, Glennen A, Lynfield R. Community-associated Methicillin-resistant Staphylococcus aureus, Minnesota, 2000-2003. Emerg Infect Dis. 2005; 11(10):1532-8. 
  • Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-44.
  • Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976-84.
  • Morin C, Hadler JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in four metropolitan areas in Connecticut, 1998. J Infect Dis 2001;184:1029-34.

Top of Page

Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more

External Web Site Policy This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    Contact CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #